ASX shares to buy for the Omicron COVID outbreak

Jitters over the Omicron COVID mutation continue to rock markets and a handful of ASX shares could represent the best …

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Jitters over the Omicron COVID mutation continue to rock markets and a handful of ASX shares could represent the best place to seek shelter.

This is despite the fact that renewed social and border restrictions is likely to take the wind out of the S&P/ASX 200 Index (Index:^AXJO).

The more infectious Omicron variant has already hit our shores and it is only a matter of time before it surfaces in the US.

ASX shares Microscope looks at an Omicron piece of jigsaw puzzle

Image source: Getty Images

Should ASX investors fear new COVID outbreak?

We won't know for weeks if Omicron is resistant to current vaccines or how severe the new strain is. The good news is that we are unlikely to see a repeat of the previous harsh lockdowns that derail economic growth.

However, ASX share investors shouldn't be too quick to celebrate, according to Macquarie Group Ltd (ASX: MQG).

"We do not expect the same level of volatility seen at the start of the pandemic, as the world has already adapted to life in a pandemic," said the broker.

"But given central banks were tapering plus diminishing fiscal stimulus and generally already high asset prices, there is a risk equity market volatility is higher than during COVID waves over the last year."

ASX shares climbing the Omicron wall of worry

In other words, while the world is better prepared to deal with COVID mutations, central banks have run out of ammo to keep supporting risk assets.

Even before Omicron, ASX share investors were already fretting over surging cases in parts of Europe. Countries like Austria and Germany were reintroducing restrictions as winter gets into full swing to contain the outbreak.

But this isn't time to throw in the towel. Macquarie has identified the ASX shares that could be beneficiaries of COVID, particularly as US cases rise.

One COVID matrix to watch

"We calculated a COVID capture ratio as the ratio of relative returns when US COVID cases were decelerating in 2021 divided by returns when cases were accelerating," explained Macquarie.

"Like a Beta, this ratio indicates the sensitivity of relative performance to changes in COVID cases."

A ratio below 1 indicates an ASX share that is more likely to outperform when COVID infections rise. A figure above 1 indicates the opposite.

Best and worst ASX shares to shelter from Omicron

Among the large cap ASX shares, those with a ratio below 1 include the Goodman Group (ASX GMG) share price and Brambles Limited (ASX: BXB) share price.

Others in the same camp are the ASX Ltd (ASX: ASX) share price and Northern Star Resources Ltd (ASX: NST) share price – just to name a few.

On the flipside, the Omicron losers include the Woodside Petroleum Limited (ASX: WPL) share price, Nine Entertainment Co Holdings Ltd (ASX: NEC) share price and Vicinity Centres (ASX: VCX) share price.

Banks and financial shares are also among the losers. These include the Westpac Banking Corp (ASX: WBC) share price, Commonwealth Bank of Australia (ASX: CBA) share price, Virgin Money UK CDI (ASX: VUK) share price and AMP Ltd (ASX: AMP) share price.

More on Broker Notes

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

A leading analyst expects Domino’s and Pro Medicus shares to keep underperforming.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Coles, Endeavour, and Rio Tinto shares

The team at Morgans has given its verdict on these popular shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Morgans names two ASX 200 shares to buy and one to sell this week

Let's see which shares Morgans is bullish and bearish on this week.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Broker Notes

Why beaten down CSL shares now offer 'long-term appeal'

A leading expert gives his outlook for CSL’s beaten down shares.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 compelling reasons to buy QBE shares today

A top expert forecasts more outperformance from QBE shares.

Read more »

Group of thoughtful business people with eyeglasses reading documents in the office.
Broker Notes

Buy, hold, or sell? Treasury Wine, Domino's Pizza, and Telstra shares

Brokers have reviewed their ratings on these 3 ASX shares amid signals of renewed market confidence this month.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

What is Morgans saying about these massively popular ASX 200 stocks?

The broker has given its verdict on these shares this week.

Read more »